A prospective randomized study of diluted versus non-diluted cardioplegia (minicardioplegia) in primary coronary artery bypass surgery

被引:0
作者
El-Hamamsy, I
Stevens, LM
Pellerin, M
Bouchard, D
Pagé, P
Carrier, M
Perrault, LP
机构
[1] Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada
[2] Montreal Heart Inst, Dept Surg, Montreal, PQ H1T 1C8, Canada
[3] Univ Montreal, Montreal, PQ, Canada
关键词
cardioplegia; coronary artery bypass; cardioplegic solutions;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim. Sanguineous (blood) cardioplegia has been established as the prime option for myocardial protection but the choice of dilution (4:1 blood to crystalloid ratio) versus use of blood from the cardiopulmonary bypass alone (minicardioplegia) remains controversial. The purpose of this prospective randomized clinical trial was to compare the clinical outcome and enzymatic endpoints (troponin I, CK-MB isoenzyme release) in patients undergoing primary CABG surgery. Methods. From June 1999 to October 2000, 59 patients were randomized preoperatively to undergo coronary artery bypass grafting surgery using cardiopulmonary bypass and either diluted (4:1 blood to crystalloid ratio; n = 25) or undiluted sanguineous cardioplegia (minicardioplegia; n = 4) at the Montreal Heart Institute. Clinical data and biochemical markers of ischemia were recorded. Tepid cardioplegia and moderate hypothermic cardiopulmonary bypass were used in 92% of patients. Results. There were no significant differences in preoperative variables between the 2 groups. There were no statistically significant differences in low output syndrome, stroke rate, arrhythmia or hospital length of stay between both groups. There was no statistically significant difference between minicardioplegia and diluted groups in the release of troponin T 24 hours postoperatively (0.36 +/- 0.31 versus 0.23 +/- 0.22, respectively). There was a slightly higher release of troponin T in the minicardioplegia group 48 hours after surgery (0.38 +/- 0.35 versus 0.20 +/- 0.16) (p = 0.03) and of CK-MB 24 hours postoperatively (22.9 +/- 18.6 versus 10.2 +/- 5.3) (p < 0.01). Conclusion. Clinical outcomes are similar in patients undergoing primary CABG surgery with tepid cardioplegia, and moderate hypothermic bypass with diluted or minicardioplegia. Minicardioplegia may be the optimal method of myocardial protection because of low cost, ease of use and lack of hemodilutive effect.
引用
收藏
页码:101 / 106
页数:6
相关论文
共 18 条
[1]   Effect of L-arginine on metabolic recovery of the ischemic myocardium [J].
Carrier, M ;
Khalil, A ;
Tourigny, A ;
Solymoss, BC ;
Pelletier, LC .
ANNALS OF THORACIC SURGERY, 1996, 61 (06) :1651-1657
[2]   Cardioplegic arrest with L-arginine improves myocardial protection:: Results of a prospective randomized clinical trial [J].
Carrier, M ;
Pellerin, M ;
Perrault, LP ;
Bouchard, D ;
Pagé, P ;
Searle, N ;
Lavoie, J .
ANNALS OF THORACIC SURGERY, 2002, 73 (03) :837-841
[3]   Antegrade/retrograde cardioplegia for valve replacement: A prospective study [J].
Dagenais, F ;
Pelletier, LC ;
Carrier, M .
ANNALS OF THORACIC SURGERY, 1999, 68 (05) :1681-1685
[4]  
Flack JE, 2000, CIRCULATION, V102, P84
[5]  
Follette D, 1980, Chir Forum Exp Klin Forsch, P279
[6]   Minimally diluted tepid blood cardioplegia [J].
Hayashida, N ;
Isomura, T ;
Sato, T ;
Maruyama, H ;
Higashi, T ;
Arinaga, K ;
Aoyagi, S .
ANNALS OF THORACIC SURGERY, 1998, 65 (03) :615-621
[7]  
LICHTENSTEIN SV, 1991, J THORAC CARDIOV SUR, V101, P269
[8]  
Luciani N, 1998, J CARDIOVASC SURG, V39, P599
[9]   Oxidative stress developed during open heart surgery induces apoptosis: Reduction of apoptotic cell death by ebselen, a glutathione peroxidase mimic [J].
Maulik, N ;
Yoshida, T .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2000, 36 (05) :601-608
[10]   SIMPLIFIED METHOD FOR DELIVERING NORMOTHERMIC BLOOD CARDIOPLEGIA [J].
MENASCHE, P ;
TOUCHOT, B ;
PRADIER, F ;
BLOCH, G ;
PIWNICA, A .
ANNALS OF THORACIC SURGERY, 1993, 55 (01) :177-178